Author:
Gschwantler Michael, ,Laferl Hermann,Vogel Wolfgang,Korak Wolfgang,Moser Stephan,Hofer Harald,Bauer Bernhard,Schleicher Michael,Bognar Barbara,Bischof Martin,Stauber Rudolf,Maieron Andreas,Ferenci Peter
Publisher
Springer Science and Business Media LLC
Reference30 articles.
1. European Association for the Study of the Liver. EASL recommendations on treatment of hepatitis C 2014. J Hepatol. 2014;61:373–95.
2. Nelson PK, Mathers BM, Cowie B, Hagan H, Des Jarlais D, Horyniak D, Degenhardt L. Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews. Lancet. 2011;378:571–83.
3. Wiessing L, Likatavicius G, Hedrich D, Guarita B, van de Laar MJ, Vicente J. Trends in HIV and hepatitis C virus infections among injecting drug users in Europe, 2005 to 2010. Eurosurveillance. 2011;16(48):9–13.
4. Grebely J, Dore GJ. What is killing people with hepatitis C virus infection? Semin Liver Dis. 2011;31:331–9.
5. Stephenson J. Former addicts face barriers to treatment for HCV. JAMA. 2001;285:1003–5.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献